Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy

BACKGROUND: Bcl-2 is positively regulated by hormonal receptor pathways in breast cancer. A study was conducted to assess the prognostic significances of clinico-pathologic variables and of ER, PR, p53, c-erbB2, bcl-2, or Ki-67 as markers of relapse in breast cancer patients who had received the ide...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Lee, Kyung-Hun, Im, Seock-Ah, Oh, Do-Youn, Lee, Se-Hoon, Chie, Eui Kyu, Han, Wonshik, Kim, Dong-Wan, Kim, Tae-You, Park, In Ae, Noh, Dong-Young, Heo, Dae Seog, Ha, Sung Whan, Bang, Yung-Jue
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2007
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1863427/
https://ncbi.nlm.nih.gov/pubmed/17430582
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-7-63
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars